Emergent BioSolutions (EBS) Reports Financial Results for Fourth Quarter and Full Year 2012
3/8/2013 6:18:57 AM
Emergent BioSolutions Inc. (NYSE: EBS) announced today its financial results for the fourth quarter and full year ended December 31, 2012.
Total revenues for 2012 were $281.9 million as compared to $273.4 million in 2011, and net income for 2012 was $23.5 million, or $0.65 per basic share, as compared to $23.0 million, or $0.65 per basic share, in 2011.
comments powered by